Search results for "Cost of Illne"

showing 10 items of 102 documents

International prevalence and risk factors evaluation for drug-resistant Streptococcus pneumoniae pneumonia

2019

Objective: Streptococcus pneumoniae is the most frequent bacterial pathogen isolated in subjects with Community-acquired pneumonia (CAP) worldwide. Limited data are available regarding the current global burden and risk factors associated with drug-resistant Streptococcus pneumoniae (DRSP) in CAP subjects. We assessed the multinational prevalence and risk factors for DRSP-CAP in a multinational point-prevalence study. Design: The prevalence of DRSP-CAP was assessed by identification of DRSP in blood or respiratory samples among adults hospitalized with CAP in 54 countries. Prevalence and risk factors were compared among subjects that had microbiological testing and antibiotic susceptibility…

0301 basic medicineMaleStreptococcus pneumoniaantibiotic resistanceInternationalitysputum examinationbronchiectasisvery elderlyAntibioticsPrevalenceDrug resistancemedicine.disease_causeLogistic regressionGlobal HealthCommunity-Acquired Infections/epidemiologylung lavage0302 clinical medicineCommunity-acquired pneumoniaCost of IllnessRisk FactorsPrevalencedrug resistant Streptococcus pneumoniae pneumonia030212 general & internal medicineMicrobial drug resistantAged 80 and overadultinternational cooperationdrug effectMiddle Agedinfluenza vaccinationAnti-Bacterial Agentsantiinfective agentEuropeCommunity-Acquired InfectionsHospitalizationGlobal burden of diseaseStreptococcus pneumoniaeInfectious Diseasesrisk factorbacterium identificationFemalecommunity acquired infectioninfluenzaliver diseasepneumococcal vaccinationPneumococcal infectionhospitalizationmedicine.drugMicrobiology (medical)medicine.medical_specialtyAsiamedicine.drug_class030106 microbiologySettore MED/10 - Malattie Dell'Apparato RespiratorioArticleAnti-Bacterial Agents/pharmacology03 medical and health sciencesInternal medicineStreptococcus pneumoniaeDrug Resistance BacterialPneumonia Pneumococcal/epidemiologymedicineHumanscontrolled studyhumantetracyclineHospitalization/statistics & numerical dataAgedlevofloxacinnonhumanbusiness.industrydisease associationmicrobiologycommunity acquired pneumoniamacrolidePneumoniaasthmaSouth AmericaPneumonia Pneumococcalvaccinationmedicine.diseasemajor clinical studyantibiotic sensitivitypenicillin derivativePenicillinStreptococcus pneumoniae/drug effectsPneumoniablood examinationAfricaNorth Americamicrobiological examinationbusinessGlobal burden of disease; Microbial drug resistant; Pneumococcal infection; Pneumonia
researchProduct

Impact of COVID-19 on global HCV elimination efforts.

2021

Background & Aims COVID-19 has placed significant strain on national healthcare systems at a critical moment in the context of hepatitis elimination. Mathematical models can be used to evaluate the possible impact of programmatic delays on hepatitis disease burden. The objective of this analysis was to evaluate the incremental change in hepatitis C liver-related deaths and liver cancer, following a 3-month, 6-month, or 1-year hiatus in hepatitis elimination program progress. Methods Previously developed models were adapted for 110 countries to include a status quo or “no delay” scenario and a “1-year delay” scenario assuming significant disruption in interventions (screening, diagnosis and …

0301 basic medicinePsychological interventioncoronavirusUMIC upper-middle income countriesGlobal HealthUI uncertainty intervalHIC high income countries0302 clinical medicineCost of IllnessLIC low income countriesMedicineUSA United States of AmericaLetter to the EditorMathematical modellingPWID people who inject drugsLiver DiseaseLiver DiseasesVaccinationmathematical modelingGBD Global Burden of DiseaseHepatitis CSVR sustained virologic responseEuropeHCV hepatitis C virusHepatocellular carcinomaHCVGHSS Global Health Sector StrategyRNA Viral030211 gastroenterology & hepatologyAMR region of the AmericasLiver cancerViral hepatitisHumanCarcinoma HepatocellularCoronavirus disease 2019 (COVID-19)EMR Eastern Mediterranean regionViral hepatitis eliminationviral hepatitisContext (language use)World Health OrganizationArticleWHO World Health OrganizationTime-to-Treatment03 medical and health scienceseliminationEnvironmental healthHumansLMIC lower-middle income countriesDisease EradicationDisease burdenHepatitisHepatologySARS-CoV-2business.industryWPR Western Pacific regionCOVID-19Models Theoreticalmedicine.diseaseCost of Illne030104 developmental biologySpainHCC hepatocellular carcinomabusinessJournal of hepatology
researchProduct

Dyadic Wind of Change: New Approaches to Improve Biopsychological Stress Regulation in Patients with Dementia and Their Spousal Caregivers

2019

Patients with dementia (PWD) and their caregivers experience long-term stress, leading to accelerated disease progression and to stress-related morbidity. Previous research focused on intrapersonal biopsychological stress responses. Quite recently, dyadic interrelations between caregivers and PWD and their effects on stress and caregiver burden have received more attention, giving rise to dyadic intervention studies. However, while it is of importance to consider both the patient and the caregiver from a dyadic point of view, evaluation of these dyadic interventions considering underlying mechanisms is still lacking. We therefore extend the current literature on dyadic processes between PWD…

0301 basic medicineStress regulationPsychological intervention03 medical and health sciences0302 clinical medicineCost of IllnessmedicineHumansDementiaIn patientSpousesPhysiological stressGeneral NeuroscienceDisease progressionGeneral MedicineCaregiver burdenmedicine.diseasePsychiatry and Mental healthClinical Psychology030104 developmental biologyCaregiversQuality of Lifebehavior and behavior mechanismsDementiaGeriatrics and GerontologyPsychologyStress Psychological030217 neurology & neurosurgeryClinical psychologyIntrapersonal communicationJournal of Alzheimer's Disease
researchProduct

The impact of direct acting antivirals on hepatitis C virus disease burden and associated costs in four European countries

2021

Eliminació del VHC; Punt d'equilibri; Infecció d'hepatitis C Eliminación del VHC; Punto de equilibrio; Infección de hepatitis C HCV elimination; Break-even; Hepatitis C infection Background and Aims We assessed the clinical and economic impact of direct-acting antiviral (DAA) therapy for hepatitis C virus (HCV) in England, Italy, Romania and Spain. Methods An HCV progression Markov model was developed considering DAA eligibility and population data during the years 2015-2019. The period of time to recover the investment in DAAs was calculated as the cost saved by avoiding estimated clinical events for 1000 standardized treated patients. A delayed treatment scenario because of coronavirus di…

:Health Care Economics and Organizations::Economics::Costs and Cost Analysis::Cost Control::Cost Savings [HEALTH CARE]DiseaseHepacivirusmedicine.disease_cause:Digestive System Diseases::Liver Diseases::Hepatitis::Hepatitis Viral Human::Hepatitis C [DISEASES]0302 clinical medicineCost of IllnessMedicine:Other subheadings::/therapeutic use [Other subheadings]Economic impact analysisChronicExit strategyevenLiver NeoplasmsHealth services researchhealthInvestment (macroeconomics)Hepatitis C:Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Infective Agents::Antiviral Agents [CHEMICALS AND DRUGS]break‐EnglandItalyHCV elimination030220 oncology & carcinogenesisOriginal Article030211 gastroenterology & hepatologyLiver Disease and Public HealthHumanHepatitis C virusSettore SECS-P/03hepatitis C infectionMedicaments antivírics- Ús terapèuticAntiviral AgentsTime-to-Treatment03 medical and health sciencesbreak-evenHumansbusinessDisease burdenDAAAntiviral Agent:economía y organizaciones para la atención de la salud::economía::costes y análisis de costes::control de costes::ahorro de costes [ATENCIÓN DE SALUD]HepaciviruHepatology:Otros calificadores::/uso terapéutico [Otros calificadores]business.industryRomania:enfermedades del sistema digestivo::enfermedades hepáticas::hepatitis::hepatitis viral humana::hepatitis C [ENFERMEDADES]COVID-19break‐evenDAAsHepatitis C ChronicEstalvi i inversióHcv eliminationCost of IllneSpain:acciones y usos químicos::acciones farmacológicas::usos terapéuticos::antiinfecciosos::antivíricos [COMPUESTOS QUÍMICOS Y DROGAS]Communicable Disease ControlVirus de l'hepatitis CbusinessDemography
researchProduct

Tailored screening and dedicated funding for direct acting antiviral drugs: How to keep Italy on the road to hepatitis C virus elimination?

2020

Background and aims. Hepatitis C virus (HCV) elimination for Italy is an ambitious, but achievable goal. In Italy, there is political will, which aims to achieve the World Health Organization (WHO) elimination goals recognizing the need to identify undiagnosed individuals in key high-risk groups and in the general population, however there is concern regarding HCV treatment implementation in Italian Regions. Methods. A modelling analysis was conducted, using the “Italy Polaris” model, to forecast the impact of different HCV treatment rates in achieving the HCV elimination goals in Italy. The model assessed two treatment scenarios: 2018 Scenario and 2019 Scenario, using the annually HCV trea…

AdultMaleAdolescentCost-Benefit AnalysisHepacivirusAntiviral AgentsGoalCohort StudiesYoung AdultCost of IllnessHumansMass ScreeningCost-Benefit AnalysiDisease EradicationAgedAged 80 and overAntiviral AgentHepaciviruIncidenceHealth PolicyMiddle AgedModels TheoreticalHepatitis CWHO elimination goalCost of IllneItalyFemaleCohort StudieInfectionGoals
researchProduct

Burden of disease assessment with summary measures of population health for the Region of Valencia, Spain: a population-based study

2011

Abstract Background and objective An important input to decision-making and health planning is a consistent and comparative description of the population health status. The purpose of this study was to describe the burden of disease in the Region of Valencia (Spain). Material and methods Disability-adjusted life years (DALYs) were calculated and divided into years of life lost (YLLs) and years lived with disability (YLDs). Using death registry data and Valencian population estimates in 2008, we calculated the number of deaths and YLLs. YLDs were based on age- and sex-specific data for countries of the EURO-A subregional level (which includes the Region of Valencia) from the Global Burden of…

AdultMaleBurden of diseaseAdolescentSense organHealth StatusPopulationPopulation healthValencianYoung AdultAge DistributionLife ExpectancyCost of IllnessCause of DeathHumansMedicineDisabled PersonsSex DistributionChildeducationDiagnosis-Related GroupsDisease burdenDepression (differential diagnoses)AgedAged 80 and overeducation.field_of_studybusiness.industryInfant NewbornInfantGeneral MedicineMiddle Agedlanguage.human_languageYears of potential life lostSpainChild PreschoolChronic DiseaselanguageFemalebusinessDemographyMedicina Clínica
researchProduct

Efficacy and effectiveness of individual family intervention on social and clinical functioning and family burden in severe schizophrenia: a 2-year r…

2009

BackgroundEmpirical evidence of the efficacy and effectiveness of psychosocial family intervention and of the specificity of its effects on the course of schizophrenia is limited. The aim was to study the efficacy and effectiveness of psychosocial family intervention with regard to clinical and social functioning and family burden after controlling for compliance and several prognostic factors.MethodA 2-year randomized controlled trial with blind assessments. Fifty patients with DSM-IV schizophrenia and persistent positive symptoms and/or previous clinical relapse were allocated to psychosocial family intervention, individual counselling and standard treatment versus individual counselling …

AdultMaleFamily therapymedicine.medical_specialtylaw.inventionYoung AdultCost of IllnessRandomized controlled triallawIntervention (counseling)Secondary PreventionmedicineHumansSchizophreniform disorderPsychiatryApplied PsychologyPsychiatric Status Rating ScalesStandard treatmentSocial environmentmedicine.diseaseCombined Modality TherapyPsychotherapyPsychiatry and Mental healthTreatment OutcomeCaregiversPsychotic DisordersSpainSchizophreniaSchizophreniaPatient ComplianceFamily TherapyFemaleSchizophrenic PsychologyPsychologySocial AdjustmentPsychosocialAntipsychotic AgentsPsychological Medicine
researchProduct

Measuring the burden of disease and injury in Spain using disability-adjusted life years: An updated and policy-oriented overview

2011

Summary Objective To provide a comprehensive and detailed overview of the burden of disease in Spain for 2008. Implications for public health policies are discussed. Study design Cross-sectional population-based study. Methods Disability-adjusted life years (DALYs) were calculated at country level using the methodology developed in the Global Burden of Disease study. DALYs were divided into years of life lost and years of life lived with disability. Results were obtained using Spanish mortality data for 2008 and morbidity data estimated previously by the World Health Organization for Euro-A. Results In 2008, DALYs lost due to all diseases and injuries were estimated at 5.1 million. Non-comm…

AdultMaleGerontologymedicine.medical_specialtyAdolescentCross-sectional studyPopulationPopulation healthYoung AdultCost of IllnessCause of DeathEnvironmental healthHumansMedicineDisabled PersonsChildeducationHealth policyDepression (differential diagnoses)Agededucation.field_of_studybusiness.industryHealth PolicyPublic healthPublic Health Environmental and Occupational HealthInfantGeneral MedicineMiddle AgedQuality-adjusted life yearCross-Sectional StudiesYears of potential life lostSpainChild PreschoolWounds and InjuriesFemaleQuality-Adjusted Life YearsbusinessPublic Health
researchProduct

Headache, anxiety and depressive disorders: the HADAS study.

2010

The objective of this paper was to assess prevalence and characteristics of anxiety and depression in migraine without aura and tension-type headache, either isolated or in combination. Although the association between headache and psychiatric disorders is undisputed, patients with migraine and/or tension-type headache have been frequently investigated in different settings and using different tests, which prevents meaningful comparisons. Psychiatric comorbidity was tested through structured interview and the MINI inventory in 158 adults with migraine without aura and in 216 persons with tension-type headache or migraine plus tension-type headache. 49 patients reported psychiatric disorders…

AdultMaleObsessive-Compulsive Disordermedicine.medical_specialtyPediatricsNeurologyOriginalAuraMigraine DisordersClinical NeurologyComorbidityNeuropsychological TestsAnxietyCost of IllnessRisk FactorsPrevalencemedicineHumansPsychiatryMigraineDepression (differential diagnoses)Depressive DisorderDepressionbusiness.industryPanic disorderTension-Type HeadacheGeneral MedicineMiddle Agedmedicine.diseaseAnxiety DisordersComorbidityCross-Sectional StudiesAnesthesiology and Pain MedicineMigrainePanic DisorderAnxietyFemaleNeurology (clinical)medicine.symptombusinessPsychopathology
researchProduct

Self-reported health and cortisol awakening response in parents of people with asperger syndrome: the role of trait anger and anxiety, coping and bur…

2013

Caring for offspring with autism spectrum disorders entails high levels of stress for a long period of time and is associated with several types of health complaints. Few studies have focused on specific effects of particular disorders in the spectrum. This study was carried out with the aim of evaluating the global health of parents of people with Asperger syndrome (N = 53) compared to those of typically developing children (N = 54) through self-reported measures (medication consumption and somatic symptoms) and biological markers (cortisol awakening response [CAR]). Additionally, we analysed various psychological variables as potential predictors of caregiver health. We found that caregiv…

AdultMaleParentsmedicine.medical_specialtyCoping (psychology)Cortisol awakening responseAdolescentHydrocortisonemedia_common.quotation_subjectPsychological interventionAngerAngerAnxietyGlobal HealthDiagnostic Self EvaluationYoung AdultCost of IllnessAdaptation PsychologicalmedicineHumansAsperger SyndromePsychiatryChildApplied PsychologyQualitative Researchmedia_commonFamily caregiversPublic Health Environmental and Occupational HealthGeneral MedicineGeneral Chemistrymedicine.diseaseCircadian RhythmCaregiversAsperger syndromeCase-Control StudiesAutismAnxietyFemaleSelf Reportmedicine.symptomPsychologyPsychologyhealth
researchProduct